cd111 24713 1 ap (Proteintech)
93
Structured Review
Proteintech
cd111 24713 1 ap
Cd111 24713 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd111+24713+1+ap/PVRL1+Antibody/pm41382272-1078-75-77
Average 93 stars, based on 12 article reviews
Cd111 24713 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd111+24713+1+ap/PVRL1+Antibody/pm41382272-1078-75-77
Average 93 stars, based on 12 article reviews
cd111 24713 1 ap - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Immunohistochemistry:Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) IHC CD3 #85061 (Cell Signaling AR TIC LE IN PR ES S 90 Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) IHC (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) Western Blot:Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) IHC CD3 #85061 (Cell Signaling AR TIC LE IN PR ES S 90 Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) IHC (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) Flow Cytometry:Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) IHC CD3 #85061 (Cell Signaling AR TIC LE IN PR ES S 90 Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) IHC (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) In Vivo:Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) IHC CD3 #85061 (Cell Signaling AR TIC LE IN PR ES S 90 Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) IHC (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) Control:Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) IHC CD3 #85061 (Cell Signaling AR TIC LE IN PR ES S 90 Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) IHC (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) |